Laser iridotomies in dark coloured irides are associated with higher complication and failure rates. A prospective clinical study to evaluate the use of the argon and Nd:YAG laser in sequential combination for iridotomy was carried out on 20 eyes of 13 patients with dark irides. Patent iridotomies were achieved in single treatment sessions for ali the eyes.
Sequential argon-YAG laser iridotomies in dark irides
Tony Ho, Richard Fan Abstract Laser iridotomies in dark coloured irides are associated with higher complication and failure rates. A prospective clinical study to evaluate the use of the argon and Nd:YAG laser in sequential combination for iridotomy was carried out on 20 eyes of 13 patients with dark irides. Patent iridotomies were achieved in single treatment sessions for ali the eyes. Iridotomy closure was observed in one eye during a mean follow-up period of 14 months (range 6-20 months). Complications from the treatment occurred in five eyes and were minor. Total mean energy used for the argon and Nd:YAG stages respectively were a third of most studies on pure argon and Nd:YAG iridotomies. Sequential argon-YAG laser iridotomy combines most of the advantages of both laser types while avoiding some of their disadvantages. We find it a safe and effective tool for iridotomy in otherwise difficult dark irides.
Laser iridotomy is now a well established procedure for the management of angle closure glaucoma and for prophylaxis in fellow eyes. Many ophthalmologists consider the Nd:YAG laser the ideal iridotorny tool especially for blue irides. However the YAG laser does not work as effectively in thick dark brown irides. The higher complication and failure rates in these patients whether by argon or YAG laser are well recognised and documented. ' Schwartz' using a pulsed argon laser reported 20% failure to penetrate in brown eyes. Quigley2 reported needing two or more sessions to achieve patent argon iridotomies in 58% of his patients with dark brown irides. Tomey3 stated that the higher amount of YAG laser energy required by his patients was attributed to the high prevalence of thick, brown irides among his patients.
Some authors45 have documented the Prior to the laser therapy all patients had a complete ophthalmic examination. Eyes with very shallow anterior chambers, iritis, or corneal oedema were excluded. Informed consent was obtained and topical pilocarpine 2% four times daily was administered the day before the procedure. After administration of topical anaesthesia an Abraham lens was inserted. Whenever possible an iris crypt in the mid-periphery was selected as the iridotomy site. The argon laser was used as the first stage laser. Initial argon laser parameters were standardised at (1) spot size 50 .tm, (2) power 700 mW, and (3) duration 0-1 second. We found it important to pre-empt the formation of a black pigment crust as this will absorb the incident laser energy without vaporising and effectively forms a barrier to further penetration. Should charring occur the duration and/or power may need to be shortened and/or reduced. Good penetration was characterised by vapour bubble formation with minimal iris charring. It was not advisable to shoot through a large vapour bubble as accurate focus and visualisation cannot be ascertained. Large vapour bubbles at the iridotomy site can be displaced easily by tapping the Abraham lens with a finger. On the other hand, we found that small vapour bubbles serve as a condensing lens and shooting through these was safe and resulted in good penetrating shots. The inital bore was made to an estimated depth of about two thirds iris thickness with an approximate diameter of 300 to 500 ,tm.
The Nd:YAG laser was used as the second stage laser to achieve iris perforation. Energy levels were set between 2 and 5 mJ depending on the surgeon's estimate of the depth of penetration Tables 2 and 3 ). The mean power used was 810 mW (SD 181, range 600-1100; Tables 2 and  3 ). It was often necessary to vary the duration of the shots during the procedure to achieve penetration and to avoid charring the iris. The duration of the argon laser shots ranged from 0 01 second to 0-1 second ( Table 2 ). For the second perforation stage, which was done using the Nd:YAG laser, the mean number of shots needed was 4 (SD 2, range 1-6; Tables 2 and 3) . Energy settings usually started off at 2 mJ depending on the surgeon's estimate ofthe depth of iris penetration achieved at the end of the first stage. The mean energy setting was 4 mJ (SD 1-2, range 2-5).
The mean total energy delivered per eye by the argon and Nd:YAG lasers respectively were 3 6 J and9-4mJ. (1) The incident laser energy is well absorbed and penetration can therefore be achieved at relatively low thermal settings, (2) hyphaema, which is a common occurrence with YAG iridotomies is uncommon, and (3) pigment dispersion is minimal compared with YAG iridotomies.
However the high energy absorption often causes significant charred pigment crust formation which acts as a barrier to further penetration. This, together with the thicker iris, Figure 2 Another example ofiridotomy achieved with this method.
Sequential argon-YAG laser iridotomies in dark irides means more shots are often needed to create a patent iridotomy. Indeed Ritch9 has reported using 300 to 400 shots with argon laser settings at 1 W power, 0-02 second duration, and 50 pm spot size in patients with dark brown irides. This is ofconcern as central endothelial cell loss due to the indirect thermal effects of the laser has been documented. 6 In our study we found the mean total energy delivered per eye by the argon and YAG respectively is only a third of the corresponding values reported for pure argon and YAG iridotomies." This should have a significant bearing on complications resulting from either direct or indirect thermal damage to the eye.
The iridotomies created were typically large, round, and with sharp margins (Figs 1 and 2 ). This is in contrast to the slit opening of YAG iridotomy and the argon iridotomy where the hole is smaller with charred edges.
Complications resulting from the treatment were minor. Microhyphaema was seen in two eyes (10%). This is in contrast to pure YAG iridotomies where about 40% are complicated by bleeding." This advantage is probably conferred by the use of the argon laser as the first stage laser.
One ofthe major advantages ofYAG iridotomy is that it is rarely associated with focal lens damage. This is because the zone of optical breakdown and plasma formation following YAG laser shots extends not distally but proximally towards the laser source, a phenomenon termed the 'plasma shield effect'. On the other hand the incidence of focal lens damage in argon iridotomy has been reported to be between 35 and 53%.'1 Our study showed a low incidence possibly due to the use of the YAG laser as the second stage laser.
Focal corneal endothelial opacity was seen in two eyes (10%) and this rate is similar to that reported by most studies on pure argon and YAG iridotomies. 
